CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.

por Ko, Young Hyeh, Kim, Sun Hee, Park, Keunchil, Ree, Howe Jung
Publicado 2002

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

por Ahn, Myung-Ju, Sun, Jong-Mu, Ahn, Jin Sock, Park, Keunchil
Publicado 2012

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

por Park, Keunchil, Wan-Teck Lim, Darren, Okamoto, Isamu, Yang, James Chih-Hsin
Publicado 2019

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer

por Sun, Jong-Mu, Hwang, Deok Won, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Publicado 2013

ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific

por de Guzman, Roselle B., Chua, Melvin L.K., Goldstein, David, Aung, Soe, Eaton, Vanessa, Park, Keunchil
Publicado 2023

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

por Kim, Youjin, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2019

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?

por Lee, Jiyun, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications

por Le Kim, Trang Huyen, Jun, Hwiseok, Kim, Jin Ho, Park, Keunchil, Kim, Jee Seon, Nam, Yoon Sung
Publicado 2017

Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell Lines

por Okabe, Sachiko, Ochiai, Yumiko, Aida, Miwa, Park, Keunchil, Kim, Seong‐Jin, Nomura, Taro, Suganuma, Masami, Fujiki, Hirota
Publicado 1999

FDG PET/CT and Mediastinal Nodal Metastasis Detection in Stage T1 Non-Small Cell Lung Cancer: Prognostic Implications

por Shin, Kyung Min, Lee, Kyung Soo, Shim, Young Mog, Kim, Jhingook, Kim, Byung-Tae, Kwon, O Jung, Park, Keunchil
Publicado 2008

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

por Byeon, Seonggyu, Ham, Jun Soo, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2016

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

por Lee, Kangkook, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?

por Jung, Hyun Ae, Park, Sehhoon, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Publicado 2020

Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

por Kim, Hongsik, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2021

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

por Kim, Hana, Park, Sehhoon, Jung, Hyun Ae, Lee, Se-Hoon, Park, Keunchil, Ahn, Yong Chan, Oh, Dongryul, Ahn, Myung-Ju
Publicado 2023

Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control stu...

por Lee, Ji Hyun, Lee, Ho Yun, Ahn, Myung-Ju, Park, Keunchil, Ahn, Jin Seok, Sun, Jong-Mu, Lee, Kyung Soo
Publicado 2016

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model

por Ku, Bo Mi, Choi, Moon Ki, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2018

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

por Kim, Hyera, Kwon, Minsuk, Kim, Binnari, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Park, Keunchil, Ahn, Myung-Ju
Publicado 2020

The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer

por Jung, Hyun Ae, Woo, Sook Young, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2020

Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement

por Jeon, Youngkyung, Jung, Hyun Ae, Park, Sehhoon, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Lee, Se-Hoon
Publicado 2023